Dr Oetker buys Noida-based start-up Kuppies to grow ready-to-eat business

The acquirer aims to generate Rs 300 cr in annual sales from RTE segment in next 5-7 years; Currently, it rakes in Rs 400 crore a year from food ingredients and ready-to-cook mixes

Dr Oetker, vegetarian mayonnaise
Dr Oetker
BS Reporter New Delhi
1 min read Last Updated : Sep 29 2021 | 4:37 PM IST
German packaged food major Dr Oetker has acquired Noida-based start-up Kuppies to expand its presence in the ready-to-eat (RTE) segment in India. The Indian units of the multinational, which gets most of its revenue from food ingredients like mayonnaise, will be using Kuppies' manufacturing unit, its innovation centre and the brand to grow its presence in RTE cakes and desserts in the local market.

According to Oliver Mirza, managing director and CEO, Dr Oetker India, the firm has set a target of generating Rs 300 crore in annual sales from the new segment within the next 5-7 years. The firm currenty rakes in some Rs 400 crore a year from its food ingredients and ready-to-cook mixes.

Incidentally, the firm gets about 75 per cent of its sales from 'Funfoods', a brand it had locally acquired in 2008.

With the acquisition, Dr Oetker will be one of the latest MNCs to enter the packaged cakes market in India in recent times. Over the past three years, a host of FMCG majors like Mondelez, ITC, General Mills, among others, have entered the Rs 2,500 crore branded RTE cake market in India.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Dr Oetkernoida

Next Story